Kingsgate Consolidated Ltd
XMUN:KCN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kingsgate Consolidated Ltd
XMUN:KCN
|
AU |
|
Arkle Resources PLC
F:48O
|
IE |
|
Akero Therapeutics Inc
F:0K4
|
US |
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
C
|
Cooper Energy Ltd
F:CDP
|
AU |
Wall St Price Targets
KCN Price Targets Summary
Kingsgate Consolidated Ltd
According to Wall Street analysts, the average 1-year price target for KCN is 5.393 EUR with a low forecast of 4.303 EUR and a high forecast of 6.629 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KCN's stock price target?
Price Target
5.393
EUR
According to Wall Street analysts, the average 1-year price target for KCN is 5.393 EUR with a low forecast of 4.303 EUR and a high forecast of 6.629 EUR.
What is the Revenue forecast for Kingsgate Consolidated Ltd?
Projected CAGR
35%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 35%.
What is the Operating Income forecast for Kingsgate Consolidated Ltd?
Projected CAGR
77%
Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 77%.
What is the Pre-Tax Income forecast for Kingsgate Consolidated Ltd?
Projected CAGR
123%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -8%. The projected CAGR for the next 3 years is 123%.
What is the Net Income forecast for Kingsgate Consolidated Ltd?
Projected CAGR
118%
Over the last 13 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 3 years is 118%.
